AI News Sentiment & Analysis
BeyondSpring Inc. (BYSI) — AI News Sentiment & Analysis
3 recent AI analyses of BeyondSpring Inc. (BYSI) stock news and press releases, with sentiment and confidence scoring updated continuously.
BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026
BullishClinical ResultsPresentation of positive updated Phase 2 clinical data for Plinabulin in metastatic NSCLC at the ASCO 2026 Annual Meeting. (Timing: Immediately)Jun 2, 2026BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
BearishEarnings ReleaseThe reported first-quarter financial results, particularly the substantial cash burn and increased net loss, will likely prompt market participants to reassess the company's financial viability and future funding prospects. (Timing: Immediate impact, unfolding over the next few quarters as cash levels are monitored.)May 13, 2026BeyondSpring Reports 2025 Year-End Financial Results
BullishFurther positive results from Plinabulin's confirmatory study and continued progress of SEED Therapeutics' early-stage drug program. (Timing: Ongoing into 2026 and beyond, with DUBLIN-4 initiation expected soon.)Mar 25, 2026
Want the full picture?
These are AI-read press-release catalysts. Sign up to see complete investment theses, valuation rationales, entry/exit strategies, and get real-time alerts.
Sign Up for FreeFrequently Asked Questions
Is BeyondSpring Inc. (BYSI) bullish or bearish right now?
AI Sentiment on BYSI: 2 Bullish, 1 Bearish.
What was the latest AI analysis for BeyondSpring Inc. (BYSI)?
The latest analysis was published on 6/2/2026 with the headline: "BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026".
How does Bekodia analyze BeyondSpring Inc. (BYSI) stock?
Bekodia uses advanced AI models to process BeyondSpring Inc. (BYSI) press releases and news in real-time, extracting sentiment, confidence scores, and key investment catalysts while filtering out market noise.